Evommune IncEVMN
Price$7.21

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $10MTTM through 31 Mar 2026
Net Income -$76MTTM through 31 Mar 2026
Free Cash Flow -$81.2MTTM through 31 Mar 2026

Margins

Current
Gross Margin0.0%

Returns

-25.0%ROE
-23.6%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio20.36x
Net Debt-$211.5Mnet cash position
Cash & Equivalents$211.5M

Quality Metrics

FCF Margin-811.5%
Earnings-Beat Rate50.0%

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.